Skip to content

Bone Biologics Corp

BBLG BBLGW

CIK 0001419554

← back to feed
Revenue (TTM)
$1.07B
0.0% YoY Q1 May 2026
Net Income (TTM)
−$3.19M
+24.4% YoY Q1 May 2026
EPS Diluted (TTM)
−$4.05
+90.8% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-0.3%
Q1 May 2026
Net Margin
-0.3%
Q1 May 2026
Free Cash Flow (TTM)
−$4.38M
Q1 May 2026
Cash
$6.19M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
1.8M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings